AU2001246657A1 - Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies - Google Patents

Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies

Info

Publication number
AU2001246657A1
AU2001246657A1 AU2001246657A AU4665701A AU2001246657A1 AU 2001246657 A1 AU2001246657 A1 AU 2001246657A1 AU 2001246657 A AU2001246657 A AU 2001246657A AU 4665701 A AU4665701 A AU 4665701A AU 2001246657 A1 AU2001246657 A1 AU 2001246657A1
Authority
AU
Australia
Prior art keywords
insufficiencies
superoxide dismutase
analogues
treating hepatocellular
hepatocellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001246657A
Other languages
English (en)
Inventor
Frederic Batteux
Pierre-Jacques Ferret
Bernard Weill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Paris 5 Rene Descartes
Original Assignee
Universite Paris 5 Rene Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Paris 5 Rene Descartes filed Critical Universite Paris 5 Rene Descartes
Publication of AU2001246657A1 publication Critical patent/AU2001246657A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01006—Catalase (1.11.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01009—Glutathione peroxidase (1.11.1.9)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
    • C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
    • C12Y115/01001—Superoxide dismutase (1.15.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001246657A 2000-03-28 2001-03-28 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies Abandoned AU2001246657A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0003887 2000-03-28
FR0003887A FR2806911B1 (fr) 2000-03-28 2000-03-28 Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires
PCT/FR2001/000939 WO2001072327A2 (fr) 2000-03-28 2001-03-28 Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires

Publications (1)

Publication Number Publication Date
AU2001246657A1 true AU2001246657A1 (en) 2001-10-08

Family

ID=8848555

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001246657A Abandoned AU2001246657A1 (en) 2000-03-28 2001-03-28 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies

Country Status (9)

Country Link
US (1) US20030118577A1 (fr)
EP (1) EP1267881B1 (fr)
JP (1) JP2003528152A (fr)
AT (1) ATE303151T1 (fr)
AU (1) AU2001246657A1 (fr)
CA (1) CA2404077A1 (fr)
DE (1) DE60113078T2 (fr)
FR (1) FR2806911B1 (fr)
WO (1) WO2001072327A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
US7699964B2 (en) 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US8165651B2 (en) 2004-02-09 2012-04-24 Abbott Diabetes Care Inc. Analyte sensor, and associated system and method employing a catalytic agent
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US20100086519A1 (en) * 2008-10-03 2010-04-08 The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center Treatment of Hepatitis C Infection With Metalloporphyrins
CN105899132B (zh) 2013-12-31 2020-02-18 雅培糖尿病护理公司 自供电分析物传感器以及使用其的装置
CN113693189B (zh) * 2021-09-28 2023-11-17 中国农业科学院北京畜牧兽医研究所 锰过氧化物酶用于降解棒曲霉素的应用及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0653670B2 (ja) * 1985-10-28 1994-07-20 日研フ−ド株式会社 化学療法剤の副作用低減化剤
ES2083357T3 (es) * 1987-03-14 1996-04-16 Boehringer Ingelheim Int Manganeso-superoxido-dismutasa humana (hmn-sod).
JPS6490133A (en) * 1987-09-29 1989-04-06 Otsuka Pharma Co Ltd Pharmaceutical preparation for oral administration
JPH01238537A (ja) * 1988-03-18 1989-09-22 Toyo Jozo Co Ltd 肝障害治療剤
JPH0420285A (ja) * 1990-05-15 1992-01-23 Asahi Chem Ind Co Ltd Ｓｏｄ誘導体
CA2072934C (fr) * 1991-07-19 2007-08-28 Karl William Aston Complexes de manganese et de ligands macrocycliques contenant de l'azote, efficaces comme catalyseurs de la dismutation de superoxydes
US5834509A (en) * 1992-12-07 1998-11-10 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US6204259B1 (en) * 1993-01-14 2001-03-20 Monsanto Company Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
NZ285648A (en) * 1994-05-13 1999-08-30 Monsanto Co Use of a metal complex as a metal peroxynitrite decomposition catalyst to treat diseases which are affected by accelerated decomposition of peroxynitrite
CA2309154C (fr) * 1997-11-03 2010-02-16 Duke University Porphyrines substituees
WO2000023568A2 (fr) * 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Procedes et compositions permettant de reduire la surproduction de mitochondries des especes oxygene reactives dans les cellules
DK1147179T3 (da) * 1999-01-19 2009-03-09 Univ North Carolina Humane lever-progenitorer
EP1616869B1 (fr) * 1999-01-25 2012-04-04 National Jewish Health Prophirines substituees et leur utilisation therapeutique

Also Published As

Publication number Publication date
ATE303151T1 (de) 2005-09-15
JP2003528152A (ja) 2003-09-24
WO2001072327A3 (fr) 2002-03-28
EP1267881B1 (fr) 2005-08-31
DE60113078T2 (de) 2006-07-13
CA2404077A1 (fr) 2001-10-04
US20030118577A1 (en) 2003-06-26
FR2806911B1 (fr) 2003-01-10
DE60113078D1 (de) 2005-10-06
FR2806911A1 (fr) 2001-10-05
WO2001072327A2 (fr) 2001-10-04
EP1267881A2 (fr) 2003-01-02

Similar Documents

Publication Publication Date Title
MY127961A (en) Beta-amino heterocyclic dipetidyl peptidase inhibitors for the treament or prevention of diabetes
MY126527A (en) Novel dihydropyrimidines
AU2003274071A1 (en) Dosage form that is safeguarded from abuse
WO2004021968A3 (fr) Solution destinee a une application ungueale et peri-ungueale
MXPA02011288A (es) Tioacetamidas substituidas.
HK1045852A1 (en) Polyurethane solutions containing alkoxysilane structural units
TW200510343A (en) Substituted dihydroquinazolines
MXPA04003796A (es) Tioacetamidas sustituidas.
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU2001246657A1 (en) Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies
LT2004074A (en) Matricines metalproteinazes inhibuojanti kompozicija neoplazinems ligoms gydyti
YU11402A (sh) Nova primena docetaksela za lečenje hepatoma
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
NZ541231A (en) A method of treatment or prophylaxis of symptoms of herpes viral infection
EP1620061A4 (fr) Agents antiviraux destines au traitement, a la regulation et a la prevention d'infections a coronavirus
HK1045258A1 (en) Glutathione reductase for therapy and prophylaxis of aids
WO2003045428A3 (fr) Utilisation d'une cellule techniquement modifiee en tant que vaccin pour traiter une tumeur
AU2001252278A1 (en) Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance
GR1004434B (el) Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων
WO2003072047A3 (fr) Compositions d'iodothyronine
UA85561C2 (ru) Применение клеточных стенок дрожжей для лечения или профилактики гипергликемии или для стабилизации содержания сахара в крови
AU3145400A (en) Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
PL377056A1 (pl) Nowe związki przeciwnowotworowe
AP1731A (en) Use of an inhibitor of the renin-angiotensin system for the manufacture of a medicament or prevention of lipodystrophy syndorme.
AU6301398A (en) Arrestable therapeutic viral agent